5
Dec
Pediatric Exclusivity: How the FDA Extends Market Protection for Drugs Without Changing Patents
Pharmacy

Pediatric Exclusivity: How the FDA Extends Market Protection for Drugs Without Changing Patents

Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested pediatric studies. It doesn't extend patents-it blocks generic approval. Here's how it works, who benefits, and why it matters.

Gareth Windham